Asahi Kasei Pharma to Sponsor Research for Drug Discovery Research and Technology: Open Innovation 2023
Up to US$200,000 funding per year for each selected proposal, up to 3 years Targeting autoimmune disease, renal disease, pain and neurodegenerative disease, bone disease or platform technologies